HIF1A and endometrial cancer: In addition, larger, more comprehensive studies incorporating diverse histological types, adjuvant treatment modalities, molecular classification, and comorbidities are needed to fully understand the complex interplay between HIF-1α, GLUT-1, and other factors in endometrial cancer.